Rui Curi graduated in pharmacy-biochemistry at the Maringá State University. He postgraduated at the Physiology and Biophysics Department of the Institute of Biomedical Science at the University of São Paulo. He was a Visiting Postdoctoral Fellow at Oxford University, University Libre de Bruxelle, National Institute of Health (NIH-USA), and Uniformed Services University of Health Sciences (USUHS-USA). His major research area is intermediary metabolism and its regulation. He contributed to the understanding of glutamine metabolism in leukocytes and its role in regulating cell function. He was the first to report glutamine utilization by neutrophils and its importance for regulation of integrity and death. He described the phenomenon of lipid transfer (fatty acids, cholesterol, and phospholipids) between cells in particular leukocytes. The effects of dietary lipids on leukocyte function were investigated by his group and found that parenteral diets rich in lipids cause leukocyte death. He participated in work leading to the discovery of NADPH complex in pancreatic islets and its involvement in beta-cell death induced by glucose, fatty acids, and interleukins. He serves as a Member of the Editorial Board of Cell Biochemistry and Function (London) and American Journal of Biomedical Sciences and other Brazilian journals. He supervised 25 M.S degree theses, 41 Ph.D. theses, and 17 postdoctors. Rui Curi is Director of the Institute of Biomedical Sciences, São Paulo University since July 2009. He was Directory Member of the Brazilian Physiological Society and Brazilian Feeding and Nutrition Society. He has published two scientific books (on glutamine and fatty acids), one technical book (cell culture), one book on practical classes of physiology, and one textbook on basic physiology. He has published over 360 scientific articles in international journals, has over four thousands scientific citations and H factor of 35 (source ISI Web of Science).
Biography Updated on 26 January 2011